XML 58 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of the Net Purchase Price and Allocation to the Acquired Assets (Detail) - ProstaGene, LLC - USD ($)
$ in Thousands
6 Months Ended
Nov. 30, 2020
May 31, 2020
Business Acquisition, Contingent Consideration [Line Items]    
CytoDyn Inc. equity $ 11,558  
Acquisition expenses 741  
Release of deferred tax asset 2,827  
Total cost of acquisition 15,126  
Intangible assets 15,126 $ 15,126
Other 0  
Allocation of acquisition costs $ 15,126